Challenges and Opportunities in Medtech, Innovation, and Digital Health
Stephen W. Bernstein
A recent McDermott round table on European health private equity generated key insights into the future of medtech, digital health, and data analytics, and identified opportunities for companies and investors. Read More.
Chinese Outbound Investments: The Seller’s Perspective
Dr. Nikolaus von Jacobs
Generally, an outbound investment by a Chinese enterprise must be approved by the competent national authorities or their local bodies before it can be closed. Read More.
Trends, Opportunities and Drivers in Early-Stage Life Sciences Investing
Byron S. Kalogerou
Despite trade wars and economic shifts in China and the European Union, early-stage investing in life sciences, particularly in the biotechnology and medical device sectors, remains strong and presents myriad opportunities for the prepared. Read More.
Stop! The CMA has Jurisdiction to Review your Transaction
Joel R. Grosberg
The UK Competition and Markets Authority (CMA) is actively and aggressively investigating mergers and acquisitions pre- and post-closing, including transactions that do not appear to have a significant UK connection. Read More.
Revised Rules Push the Milan Chamber of Arbitration on to the International Stage
Lisa M. Richman
On 1 March 2019, the Milan Chamber of Arbitration (CAM), the leading Italian arbitration institution, issued its revised Arbitration rules. These are intended to provide for a more efficient administration of arbitral proceedings. Read More.
Insights on China’s RoHS Regulations
| James Jiang | Joyce Xie
All electrical and electronic products that are produced, sold or imported in mainland China must comply with the Administrative Measures on the Restricted Use of Hazardous Substances in Electrical and Electronic Products (China RoHS 2.0). Read More.